greeksoup/ stocks
Stocks / India / DIVISLAB / Q3 FY2025

Divi's Laboratories Ltd. Q3 FY2025 results: revenue ₹2,319 crore, up 25.0% on the year

Divi's Laboratories Ltd. (DIVISLAB) reported consolidated revenue from operations of ₹2,319 crore for Q3 FY2025, the quarter ended 31 December 2024, up 25.0% on the same quarter a year earlier. Profit after tax was ₹589 crore, up 64.5% on the year, and earnings per share ₹22.20. The figures are the company's own, from the unaudited results it filed with NSE on 3 February 2025.

Revenue from operations₹2,319 croreup 25.0%
Profit after tax₹589 croreup 64.5%
EPS₹22.20
QuarterQ3 FY2025ended 31 December 2024

The quarter, against the one before and a year earlier

LineQ3 FY2025Q2 FY2025Q3 FY2024Change on the year
Revenue from operations2,3192,3381,855+25.0%
Other income8210695-13.7%
Total income2,4012,4441,950+23.1%
Cost of materials consumed1,021976794+28.6%
Purchases of stock-in-trade000n/a
Changes in inventories-99-7-65n/a
Employee benefit expense297304268+10.8%
Finance costs010n/a
Depreciation, depletion and amortisation999995+4.2%
Other expenses357349369-3.3%
Total expenses1,6751,7221,461+14.6%
Profit before exceptional items and tax726722489+48.5%
Exceptional items000n/a
Profit before tax726722489+48.5%
Current tax174218122+42.6%
Deferred tax-37-69n/a
Total tax137212131+4.6%
Profit after tax589510358+64.5%
Attributable to owners of the parent589510358+64.5%
Other comprehensive income115-80.0%
Total comprehensive income590511363+62.5%
EPS, basic₹22.20₹19.20₹13.50+64.4%
EPS, diluted₹22.20₹19.20₹13.50+64.4%

₹ crore except per share.

Quarterly results, the last 12 quarters

Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Sales1,9091,8552,3032,1182,3382,3192,5852,4102,7152,6042,8313,080
Expenses1,5261,4611,6691,5931,7221,6751,8071,7961,9481,8382,0231,964
Operating profit4794897316227167438867298888909341,255
OPM %25%26%32%29%31%32%34%30%33%34%33%41%
Other income8695797910682861191458815564
Interest102010138666
Depreciation959595979999107112113118120133
Exceptional items000000000-7400
Profit before tax4694897136047227268647339127809631,180
Tax %26%27%25%29%29%19%23%26%24%25%22%24%
Net profit348358538430510589662545689583751902
EPS in ₹₹13.11₹13.50₹20.25₹16.20₹19.20₹22.20₹24.93₹20.49₹25.97₹21.98₹28.31₹33.95
FilingNSENSENSENSENSENSEFilingFilingFilingFilingFilingFiling

₹ crore except per share, consolidated, as filed with the exchange. Operating profit is sales less the expenses other than interest and depreciation, OPM is that over sales, and tax % is tax over profit before tax: arithmetic on the filed lines; everything else is as filed. Quarters before December 2024 are from the exchange's earlier results feed, which carries the filed lines without the filing itself; the column links to the exchange's page for the company.

Source

Unaudited consolidated results for the quarter ended 31 December 2024, filed with NSE on 3 February 2025: the result statement. All of Divi's Laboratories Ltd.'s results: NSE company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install